PubMed · 7376647
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
B H Rumack, R G Peterson. 1980. Acetaminophen toxicity.. https://pubmed.ncbi.nlm.nih.gov/7376647/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The gastrointestinal transit and in vivo drug release behaviour of a film-coated tablet formulation was investigated in five healthy human subjects using the technique of gamma scintigraphy. The film coating system consisted of a mixture of pectin, chitosan and HPMC in a ratio of 6:1:0.37 applied to 750 mg cores at a coat weight gain of 9%. The estimated mean values of the gastric emptying time (62+/-17 min), small intestinal transit time (219+/-53 min), ileocaecal junction lag time (79+/-30 min) and the colon arrival time (345+/-33 min), were similar to published values for the transit of similar sized tablets in humans. The amount of radioactive tracer released from the labelled tablets was minimal when the tablets were in the stomach and the small intestine. There was increased release of radioactivity when the tablets were in the colon due to increased degradation of the film coatings by pectinolytic enzymes resident in the colon. The pectin/chitosan/HPMC film coating system thus acts as a colonic delivery system.
In this work, a simple and rapid analytical procedure was proposed for simultaneous determination of acetylsalicylic acid (ASA), paracetamol (PRC, also known as acetaminophen) and caffeine (CAF) in pharmaceutical formulations based on multivariate calibration and UV spectrophotometric measurements (210-300 nm). The calibration set was constructed with nine solutions in the concentration ranges from 10.0 to 15.0 microg x ml(-1) for ASA and PRC and from 2.0 to 6.0 microg x ml(-1) for CAF, according to an experimental design. The procedure was repeated at four different pH values: 2.0, 3.0, 4.0 and 5.0. Partial least squares (PLS) models were built at each pH and used to determinate a set of synthetic mixtures. The best model was obtained at pH 5.0. An N-way PLS model was applied to a three-way array constructed using all the pH data sets and enabled better results. This calibration model provided root mean squares errors of prediction (RMSEP) from 11.5 to 35% lower than those obtained with PLS at pH 5.0, depending on the analyte. The results achieved for the determination of these drugs in commercial tablets were in agreement to the values specified by the manufactures and the recovery was between 94.7 and 104.5%.
A high-performance liquid chromatography (HPLC) method has been developed and validated for the simultaneous determination of n-propionyl-p-aminophenol, 3-chloro-4-hydroxyacetanilide, 4'-hydroxyacetophenone, 4-hydroxyacetophenone oxime, 4-acetoxyacetanilide and 4'-chloroacetanilide, the main impurities in acetaminophen drug substance. The chromatographic separation was achieved on an Eclipse XDB-18 reversed-phase column using a gradient elution, being solvent A: 0.01 M phosphate buffer at pH 3.0 and solvent B: methanol. The limit of quantitation (S/N=10:1) was 0.1 microg/ml for each impurity. The coefficients of variation were less than 4% for intra-day and inter-day analyses. The individual recovery of acetaminophen spiked samples ranged from 94 to 104% and the mean recovery for each level from 99 to 103% in the 1-150 microg/ml range for all impurities. The proposed method was successfully applied to the analyses of different lots and different manufactures of acetaminophen drug substance. The proposed method can be used for the routine quality control of acetaminophen.